HIV drug-resistance patient registry study for people 14+
Part of Immune system & allergy, Infections clinical trials.
This study is a registry (a way to collect and organize information) for people living with HIV who have drug-resistant virus. It may help researchers better understand how resistant HIV behaves and how to manage treatment over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have HIV-1 infection
- You are older than 14 years
- Your HIV virus must show resistance in all 4 drug groups
- For each group (NRTI, NNRTI, PI, and INI), at least one drug must be resistant
- The resistance can be found from past testing or from testing done before joining
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how drug resistance mutations in HIV might affect how well certain treatments work, including two-drug regimens. It aims to help doctors choose the best medicines for each person.
This study looks at how the immune system and HIV behave in people on long-term HIV treatment (ART), using blood samples that will be stored for future tests for up to 20 years. It may help researchers understand how well treatment is controlling HIV and improve future care.
This study looks at how well newer HIV medicines work in people starting treatment for the first time in Eastern Europe and Russia. It also checks for drug resistance to find better treatment strategies.
This study follows people living with HIV who have undetectable viral loads to see how well a long-acting injectable medication (cabotegravir plus rilpivirine) works in real-world conditions. It may help understand if this injection-based treatment can reliably keep HIV controlled with fewer pills.
This study looks for drug-resistant HIV strains in people whose virus is not fully controlled by their current treatment. It aims to help doctors understand why the virus is still detectable.
This trial is a pregnancy registry that collects information about birth outcomes when certain HIV medicines are taken during pregnancy. It helps detect any major birth defects so future pregnancies can be safer.
Hear when a new HIV-1-infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.